Montreal Heart Institute to Use $5.1M Grant on PGx Studies for ACS Drug | GenomeWeb

Montreal Heart Institute to Use $5.1M Grant on PGx Studies for ACS Drug

Oct 08, 2007

NEW YORK (GenomeWeb News) — The Montreal Heart Institute has been awarded a CAN$5 million ($5.1 million) grant to fund a research project based on its academic and private partnerships in pharmacogenomics, MHI said late last week.

The funding was awarded as part of a Genome Quebec competition aimed at fostering public and private participation in developing personalized medical technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.